The PD-1/PD-L1 (B7-H1) pathway in chronic infection-induced cytotoxic T lymphocyte exhaustion.
about
Can tissue-based immune markers be used for studying the natural history of cancer?New immunotherapies targeting the PD-1 pathwayKiller-cell immunoglobulin-like receptors (KIR) in severe A (H1N1) 2009 influenza infections.Getting "Inside" Type I IFNs: Type I IFNs in Intracellular Bacterial InfectionsGlial cells suppress postencephalitic CD8+ T lymphocytes through PD-L1.Compartmentalization of simian immunodeficiency virus replication within secondary lymphoid tissues of rhesus macaques is linked to disease stage and inversely related to localization of virus-specific CTL.Clonal expansions of CD8+ T cells with IL-10 secreting capacity occur during chronic Mycobacterium tuberculosis infectionThe role of programmed cell death ligand-1 (PD-L1/CD274) in the development of graft versus host diseaseA randomized, double-blind, placebo-controlled assessment of BMS-936558, a fully human monoclonal antibody to programmed death-1 (PD-1), in patients with chronic hepatitis C virus infection.Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway.Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses.Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcomaDelineation of antigen-specific and antigen-nonspecific CD8(+) memory T-cell responses after cytokine-based cancer immunotherapy.CD8+ T cell exhaustion, suppressed gamma interferon production, and delayed memory response induced by chronic Brucella melitensis infection.Type 1 interferon-induced IL-7 maintains CD8+ T-cell responses and homeostasis by suppressing PD-1 expression in viral hepatitisB7x in the periphery abrogates pancreas-specific damage mediated by self-reactive CD8 T cells.Role of soluble programmed death-1 (sPD-1) and sPD-ligand 1 in patients with cystic echinococcosis.HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell functionNetworking at the level of host immunity: immune cell interactions during persistent viral infectionsEffects of lung cancer cell-associated B7-H1 on T-cell proliferation in vitro and in vivo.Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1.Phenotypic alteration of CD8+ T cells in chronic lymphocytic leukemia is associated with epigenetic reprogramming.Augmentation of cellular and humoral immune responses to HPV16 and HPV18 E6 and E7 antigens by VGX-3100Changes in immune cell populations in the periphery and liver of GBV-B-infected and convalescent tamarins (Saguinus labiatus)Structure-guided development of a high-affinity human Programmed Cell Death-1: Implications for tumor immunotherapy.Peptide-MHC multimer-based monitoring of CD8 T-cells in HIV-1 infection and AIDS vaccine development.Programmed death-1 & its ligands: promising targets for cancer immunotherapy.Treatment options for progressive multifocal leukoencephalopathy in HIV-infected persons: current status and future directions.Prospect of the use of checkpoint inhibitors in hepatocellular cancer treatments.Immunotherapy against cancer-related viruses.High expression of PD-1 ligands is associated with kataegis mutational signature and APOBEC3 alterations.The role of programmed death ligand 1 pathway in persistent biomaterial-associated infections.Immunological memory to blood-stage malaria infection is controlled by the histamine releasing factor (HRF) of the parasite.Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1.Functional polymorphisms in CD86 gene are associated with susceptibility to pneumonia-induced sepsis.PD-1/PD-L1 signal pathway participates in HCV F protein-induced T cell dysfunction in chronic HCV infection.PD-1 mRNA expression in peripheral blood cells and its modulation characteristics in cancer patients.Immunotherapy for lung cancer.Influenza infection results in local expansion of memory CD8(+) T cells with antigen non-specific phenotype and function.Imbalance between circulating CD4+ regulatory T and conventional T lymphocytes in patients with HBV-related acute-on-chronic liver failure.
P2860
Q24605537-8AFB28E9-5FC7-4581-BC98-752A8D111B5AQ27010018-B0E9AEEE-B8D1-4953-86AE-50F64F6D9683Q30417443-C7E7472A-9915-4CFE-B960-1517E1C3741EQ33655568-92A5F0BE-6DD3-4B92-AFDC-5AF9A08A923DQ34076317-7F67D91A-32DF-4A24-9D18-A7E565E0E4BDQ34550802-18C0EB33-C68E-48B5-87FA-751D0AC67ECCQ34615073-BC72BBE6-5255-4150-972D-A93C07636EBDQ34673038-6CD4B386-016B-473A-AA50-1C01A1303465Q34744674-0B60CD9C-87AC-4AFF-9183-941725B7EDE5Q34809019-13DF3947-6AE1-44FD-A09B-FC2CD1462ACAQ35049821-94E39E29-AE21-4379-A54C-B75ECAC2ED5BQ35624496-C255E176-7907-472E-8FED-1D09E26D6AC2Q35876982-186CA868-9911-4707-BA83-F18DC0029DCFQ36281282-615EDD81-3689-4043-B285-2A1094A3A6F5Q36302605-EEC2062F-D987-4EC4-B682-29C096190741Q36303510-70C2772B-F7FF-4588-9485-3DB2D822D0F4Q36502070-FB716F59-FF13-4B90-BF82-8D93112C5521Q36932447-4D6F4792-13DC-4897-8B4A-DDC8E6A1BE5DQ37020616-AFB4B413-C780-423A-8888-98533B8C18E0Q37032948-E5CD51D9-4B93-4884-96E9-A9163CBD381BQ37158481-CBBFFA57-5715-4866-8065-4E680FDC2EB2Q37457945-46AD44EC-B6E3-4A84-A24A-CF67521D9A91Q37489634-6D63ECFE-7C5F-47DE-A30D-A49AFEE79895Q37671532-0AAD8CD0-4D4A-442C-BD6D-AB9A006D8A82Q37714274-DB3C2594-50EB-4D21-9208-C5A9B3C8A90FQ38265356-E48E4DDF-4649-48F9-8DEB-0ABC0DBE2434Q38562062-FA066055-0666-4FF9-9EBC-707C8B63AB15Q38665891-77062489-756E-4829-A954-079AF6ECD193Q38754730-9CC80ED7-4F3C-493B-BD44-89F53721FE6EQ38778924-7301ACB6-80A7-431B-AEE2-4938162FB9B9Q38839124-9EF55EC3-FBB4-4D9C-880E-446E84E5608CQ38847988-1CD94B60-7F62-453C-95DF-064D941D23B0Q40083759-2D75E76A-E105-4962-BC7E-166BFABB0975Q40526734-3FD0BA29-8CFF-4557-AE19-B2828D6179B4Q41014829-422334DE-1BEF-43E0-83E3-427B079A4C9FQ41045077-61934667-68C8-4FCC-93FB-005D9A1E81B6Q41612447-F456EC58-E10A-4013-8288-0AD32D5A5224Q41916016-D18D0253-4E4E-456A-9224-140518D1DF09Q42277216-90126463-8951-4AA8-A5BB-770DC1482D00Q42282784-80BE9266-2BD2-4B03-B4C7-52981E4F9DF9
P2860
The PD-1/PD-L1 (B7-H1) pathway in chronic infection-induced cytotoxic T lymphocyte exhaustion.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The PD-1/PD-L1 (B7-H1) pathway ...... toxic T lymphocyte exhaustion.
@en
The PD-1/PD-L1
@nl
type
label
The PD-1/PD-L1 (B7-H1) pathway ...... toxic T lymphocyte exhaustion.
@en
The PD-1/PD-L1
@nl
prefLabel
The PD-1/PD-L1 (B7-H1) pathway ...... toxic T lymphocyte exhaustion.
@en
The PD-1/PD-L1
@nl
P2093
P2860
P921
P356
P1476
The PD-1/PD-L1 (B7-H1) pathway ...... toxic T lymphocyte exhaustion.
@en
P2093
Hyungjun Jeon
Kimberly A Hofmeyer
Xingxing Zang
P2860
P304
P356
10.1155/2011/451694
P577
2011-09-25T00:00:00Z